02/18/2025
5:16 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/27/2025
6:57 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/21/2025
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2025
7:16 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/10/2025
5:01 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2024
6:03 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/09/2024
5:04 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024
5:03 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2024
5:02 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/19/2024
5:01 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for IPHYF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. |
11/13/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/08/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2024
6:03 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024
5:11 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024
5:15 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024
5:03 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2024
5:15 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2024
5:07 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024
3:00 PM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/09/2024
5:13 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024
5:10 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2024
5:11 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2024
5:06 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2024
6:43 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024
5:02 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024
5:03 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
5:03 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
5:35 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024
5:01 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
5:07 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024
5:03 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
5:02 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2024
5:51 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
7:03 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/21/2024
8:20 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2024
5:01 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024
5:33 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
6:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
$5,000 DOGE check? (Ad) Elon Musk's DOGE agenda just took a very surprising turn...
Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers.
The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail. Everything you need to know is right here. |
03/06/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
